Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.
2.

High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.

Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J.

J Clin Endocrinol Metab. 2000 Oct;85(10):3653-60.

PMID:
11061518
[PubMed - indexed for MEDLINE]
3.

Effect of growth hormone treatment on adult height of children with idiopathic short stature. Genentech Collaborative Group.

Hintz RL, Attie KM, Baptista J, Roche A.

N Engl J Med. 1999 Feb 18;340(7):502-7.

PMID:
10021470
[PubMed - indexed for MEDLINE]
Free Article
4.

Prehospital and emergency department delays after acute stroke: the Genentech Stroke Presentation Survey.

Morris DL, Rosamond W, Madden K, Schultz C, Hamilton S.

Stroke. 2000 Nov;31(11):2585-90.

PMID:
11062279
[PubMed - indexed for MEDLINE]
Free Article
5.

Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc., Collaborative Study Group.

Chernausek SD, Attie KM, Cara JF, Rosenfeld RG, Frane J.

J Clin Endocrinol Metab. 2000 Jul;85(7):2439-45.

PMID:
10902791
[PubMed - indexed for MEDLINE]
6.

Intracranial hypertension in pediatric patients treated with recombinant human growth hormone: data from 25 years of the Genentech National Cooperative Growth Study.

Noto R, Maneatis T, Frane J, Alexander K, Lippe B, Davis DA.

J Pediatr Endocrinol Metab. 2011;24(9-10):627-31.

PMID:
22145447
[PubMed - indexed for MEDLINE]
7.

Newsmaker interview. Genentech scientist to take the helm at Rockefeller University. Interview by Greg Miller.

Tessier-Lavigne M.

Science. 2010 Sep 17;329(5998):1456. doi: 10.1126/science.329.5998.1456. No abstract available.

PMID:
20847242
[PubMed - indexed for MEDLINE]
8.

Erlotinib OSI/Roche/Genentech.

Kim TE, Murren JR.

Curr Opin Investig Drugs. 2002 Sep;3(9):1385-95. Review.

PMID:
12498017
[PubMed - indexed for MEDLINE]
9.

Technology evaluation: pertuzumab, Roche/Genentech/Chugai.

Spicer J.

Curr Opin Mol Ther. 2004 Jun;6(3):337-43. Review.

PMID:
15264437
[PubMed - indexed for MEDLINE]
10.

Technology evaluation: bevacizumab, Genentech/Roche.

Salgaller ML.

Curr Opin Mol Ther. 2003 Dec;5(6):657-67.

PMID:
14755893
[PubMed - indexed for MEDLINE]
11.

Genentech obtains proof of concept for hedgehog inhibition.

Sheridan C.

Nat Biotechnol. 2009 Nov;27(11):968-9. doi: 10.1038/nbt1109-968. No abstract available.

PMID:
19898437
[PubMed - indexed for MEDLINE]
12.

Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. The Genentech Growth Study Group.

Blethen SL, Baptista J, Kuntze J, Foley T, LaFranchi S, Johanson A.

J Clin Endocrinol Metab. 1997 Feb;82(2):418-20.

PMID:
9024229
[PubMed - indexed for MEDLINE]
13.

Pharmaco-toxicological expert report Pulmozyme rhDNase Genentech, Inc.

Green JD.

Hum Exp Toxicol. 1994 May;13 Suppl 1:S1-42. Review. No abstract available.

PMID:
8031609
[PubMed - indexed for MEDLINE]
15.

Technology evaluation: omalizumab, Genentech/Novartis/Tanox.

Lazaar AL.

Curr Opin Mol Ther. 2003 Feb;5(1):81-9.

PMID:
12669476
[PubMed - indexed for MEDLINE]
16.

Genentech and IDEC await approval of lymphoma Mab.

[No authors listed]

Nat Biotechnol. 1997 Apr;15(4):301. No abstract available.

PMID:
9094110
[PubMed - indexed for MEDLINE]
17.

Growth hormone therapy in Turner's syndrome: an update on final height. Genentech National Cooperative Study Group.

Rosenfeld RG.

Acta Paediatr Suppl. 1992 Sep;383:3-6; discussion 7.

PMID:
1458013
[PubMed - indexed for MEDLINE]
18.

Outcome of a four-year randomized study of daily versus three times weekly somatropin treatment in prepubertal naive growth hormone-deficient children. Genentech Study Group.

MacGillivray MH, Baptista J, Johanson A.

J Clin Endocrinol Metab. 1996 May;81(5):1806-9.

PMID:
8626839
[PubMed - indexed for MEDLINE]
19.

Tezosentan. Actelion/Genentech.

Rossetti E, De Servi S.

Curr Opin Investig Drugs. 2003 Mar;4(3):323-8. Review.

PMID:
12735233
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk